Zoledronic acid as prophylaxis against glucocorticoid-induced osteoporosis in lymphoma (ZAPGIO)
Sponsor: Region Nordjylland
Phase:
Disease: Lymphoma, Glucocorticoid-induced osteoporosis
EU trial number: 2026-527220-27-00
Population: Patients with lymphoma receiving glucocorticoid-containing chemotherapy, such as R-CHOP-like treatment, assessed for prevention of glucocorticoid-induced osteoporosis and fractures.
Register Investigator Interest
Interested in offering this trial to suitable patients?